Alzchem Group Ag · XETR:ACT
Alzchem — Q3 2023 Earnings Presentation
38 slides from Alzchem's earnings presentation, Oct 26, 2023
Slide 1: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 2: Presenters: CEO and CSO, October 26, 2023
ANDREAS NIEDERMAIER, CEO 3 DR. GEORG WEICHSELBAUMER, CSO 2023 October 26, 2023
Slide 3: Disclaimer
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 4: Agenda — Analyst Presentation Q3 2023: Executive Summary
AGENDA — ANALYST PRESENTATION Q3 2023 Executive Summary
Slide 5: Highlights
© Alzchem Group AG / October 2023 HIGHLIGHTS Specialty Chemicals shifts EBITDA above prior year / guidance ad ol=s| -v rs Continuous effort to establish Alzchem more and more as a Specialty Chemicals company EBITDA is much higher than previous year while sales are slightly lower Operating cash flow
Slide 6: Markets Developments
MARKETS DEVELOPMENTS Consistent focus on the high-margin Specialty Chemicals business BASICS & INTERMEDIATES SPECIALTY CHEMICALS ® @® ORES, PHARMA EU METALLURGY ANIMAL AUTOMOTIVE HUMAN NUTRITION NUTRITION /DEFENSE (> PHARMA Row AGRICULTURE FINE CUSTOM (FERTILIZER) CHEMICALS AGRICULTURE SYNTHESIS
Slide 7: Outlook 2023
OUTLOOK 2023 (in me) Outlook adjusted; EBITDA strong growth Slight growth On prior year up to590.0ME evel 590.0 542.2 _ ___ 540.0 Slight growth up to 70.0 ME 70.0 2022 FC 2023. FC 2023 FC 2023 adjusted Strong growth to approx. 80.0 ME 80.0 | FC 2023 adjusted COMMENTS * Outlook 2023 adjusted for the
Slide 8: Verbund System — Fully Integrated Business Model
© Alzchem Group AG / October 2023 “VERBUND” SYSTEM — FULLY INTEGRATED BUSINESS MODEL Ability to adapt production to meet changing end market needs CALCIUM CYANAMIDE nTRALz* 1 RENEWABLE nd Infrastructure ENE Wan CARBON ENERGY
Slide 9: Verbund System — Health & Nutrition
© Alzchem Group AG / October 2023 “VERBUND” SYSTEM — FULLY INTEGRATED BUSINESS MODEL Health & Nutrition AE Creapure” 7 088 Creapure’ LIVA DUR 688 Creavitalis’ Premium brand for creatine monohydrate as a food supplement in sports nutrition Dietary supplement with pure creatine Creatine for health and
Slide 10: Health & Nutrition Market
© Alzchem Group AG / October 2023 HEALTH & NUTRION MARKET Creatine — what is the hype all about? Creatine is a substance produced naturally in the body. A good portion of creatine in the body is stored as phosphocreatine. Phosphocreatine is the bridge between spontaneous ATP energy and extra cellula
Slide 11: Health & Nutrition Market: Daily creatine supply and sources
sm Group AG / O=tober 2023 HEALTH & NUTRION MARKET AN Daily creatine supply and sources CREATINE SUPPLY * Approx. 50-60% of creatine demand is typically produced endogenously * Food sources for creatine are all animal based * Daily optimum level can be reached either by: * 600g raw meat * 600g raw f
Slide 12: Financial Overview
FINANCIAL OVERVIEW Positive profitability performance in a challenging environment SALES (in M€) 13.2% EBITDA (in M€) - r +60.8% EBITDA margin (in %) +7.4 pp Earnings per Share (in €) . b +44.5% Sales in first nine months slightly lower than previous year ) with different segment d pment. Specialty
Slide 13: Agenda — Business and financial details
AGENDA — ANALYST PRESENTATION Q3 2023 ll. Business and financial details
Slide 14: Basics & Intermediates
NITRALZ® CBerlka’ G CaD BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of
Slide 15: Basics & Intermediates Segment
BASICS & INTERMEDIATES SEGMENT (in m€) Volume reductions but increased EBITDA SALES ANALYSIS 59.6 443 Volume Jaa - 24.1% Q3 Q4. QI Q2- QB QA QI 2 Q3 2021 2021 2022 2022 2022 2022 2023 2023 2023 me and pr +140.6% istently high enerc ler previous year 26 d to 4.2 % in 2023 Q3 4 Qi Q2 O38 O4 Q QZ Qs 1-
Slide 16: Specialty Chemicals
a oe ( CREAMINO Drmex' Bioselect® DYHARD ##% Creapure* SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals.
Slide 17: Specialty Chemicals Segment
SPECIALTY CHEMICALS SEGMENT (in me) 2023 Sales and EBITDA growth continued and caused outlook increase SALES ANALYSIS Q3 Q4. QI QZ QB 4 QT Q2e- QB 2021 2021 2022 2022 2022 2022 2023 2023 2023 COMMENTS hemic ‘© more than with maj Q3 04. QI Q2 Q3 4 QI 02 Q3 1-9 1-9 2021 2021 2022 2022 2022 2022 2023 2
Slide 18: Other & Holding
The "Other & Holding" segment offers infrastructure and energy supply services a at our locations for the chemicals segments and for external customers. a, . | OTHER & HOLDING
Slide 19: Other & Holding Segment
OTHER & HOLDING SEGMENT (in me) Development of services in line with costs pass-through nee Q3 Q4. QI QZ QB 4 QT Q2e- QB 2021 2021 2022 2022 2022 2022 2023 2023 2023 COMMENTS 1-9 1-9 Q3 24. Qi Q2) Q3) Q4- QI Q2- QB 1-9 1-9 2022 ©2023 2021 2021 2022 2022 2022 2022 2023 2023 2023 2022 2023
Slide 20: Balance Sheet
BALANCE SHEET (in Mé€) Stable balance sheet development with improved equity ratio Other non-current assets Equity Deferred taxes for pension provision : . Other non-current liabilities Inventories ‘ fei Pension provision Trade receivables 132.1 obit, 0 Current liabilities Other current assets 31.12
Slide 21: Cashflow
CASHFLOW (in m€) Strong operating and free cashflow; reduction of short-term financing from of ‘ing activitie: first ni 20 re / ar -> in of orking cap ageme! 2 58.8 ME 8 c w and additional from financing activiti from current to non-current (30.0 lant and renewal * Further inve:
Slide 22: Financial Calendar
FINANCIAL CALENDAR Upcoming dates* “subject to change NOV 15 NOV 27-29 MAR 1 APR 30 MAY 7 AUG 1 NOV 7 2023 2023 2024 2024 2024 2024 2024 MS Minchner Kapitalmarkt Konferenz 2023 Deutsches Eigenkapitalforum 2023 Annual Report Qarterly Statement 1 Quarter 2024 Annual General Meeting Quarterly Statement
Slide 23: Feedback
FEEDBACK We appreciate your feedback Were your expectations met? Are you missing any content? WE APPRECIATE YOUR FEEDBACK! QR-Code Teer ela]
Slide 24: Investor Relations
alzchem group Investor Relations T +49 8621 86-2888 F +49 8621 86-502888 ir@alzchem.com
Slide 25: Agenda — Back-Up
AGENDA — ANALYST PRESENTATION Q3 2023 ll. Back-Up
Slide 26: Balance Sheet
© Alzchem Group AG / October 2023 BALANCE SHEET Alzchem Group MS ALZCHEM GROUP (IN TE) 31.12.2022 30.09.2023 Deviation ALZCHEM GROUP (IN TE) 31.12.2022 30.09.2023 Deviation Intangible assets 2,954 3237 283 96% Share capital 101,763 101,763 Tangible assets 181,526 110,435 “50-28% RETAINED EARNINGS (+
Slide 27: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) Alzchem Group (M€) IN FINANCIAL PENSION SERVICE NET INTEREST PENSION STATEMENT PROVISION costs costs PAYMENTS 31.12.2022 A eiNANciA RESULT BALANCE SHEET P&L CASHFLOW, Interest rates were increased from 3.7% to 4.0% All other actuari sumptions are unchanged Pension payments
Slide 28: Income Statement
© Alzchem Group AG / October 2023 INCOME STATEMENT AN Alzchem Group Gy ALECHEM GROUP (NTE) wom aim no moms aos ats zor‘ Dematon(Q3) Revenue 129,395 140,435 139,193 133,200 150,432 126,599 120,824 18,370 -13% Increase (+) / Decrease (-) in inventories of finished goods and workin progress 1414414467
Slide 29: Income Statement
© Alzchem Group AG / October 2023 INCOME STATEMENT i, XW Alzchem Group Gy Q3 3 YTD YTD ALZCHEM GROUP (IN TE) Deviation (QoQ) Deviation (YoY) 2022 2023 Sep.2022 _ Sep.2023 Revenue 139,193 120,824 718370 13.2% 409,023 397,854 11,168 “27% Increase (+) / Decrease (-) in inventories of finished goods and
Slide 30: Cashflow Statement
© Alzchem Group AG / October 2023 CASHFLOW STATEMENT Alzchem Group 5 Q3 3 1-9 1-9 CASHFLOW (IN Mg} 2022 2023 2022 2023 Consolidated earnings before taxes 7,538 12,035, 32,138 (32,782 Depraciation on fied and intangible assets 6304 6574 18927 79229 Decrease in pension provisions “375 Ast “1253 -1408
Slide 31: Segment Overview by Quarter
SEGMENT OVERVIEW BY QUARTER iN Alzchem Group v SALES SALES Deviation PY (23) Te % Basics & Intermediates 46,038 15,286 -26% Specialty Chemicals 73,72 “3,421 -5% Other and Holding 6, 8 7,389 37 5% Alzchem Group, 111,000 11,052 129,395 140,425 139,193 133,200 150,432 126,599 120,824 18,370 13% EBITDA
Slide 32: Executive Team
EXECUTIVE TEAM Alzchem Group AG me n- om : fem = DR. GEORG WEICHSELBAUMER CSO BEI ALZCHEM SEIT 2012 RESSORTVERANTWORTUNG Marketing, Vertrieb, Innovationsmanagement & Verfahrensentwicklung, F&E, Produktsicherheit /-zulassung ANDREAS NIEDERMAIER CEO BEI ALZCHEM SEIT 1999 RESSORTVERANTWORTUNG Finanzen
Slide 33: Alzchem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies COVENTRY (UK) SHANGHAI (CN) Pa ATLANTA (USA) © Alzchem Group AG / August 2022
Slide 34: Verbund — Fully Integrated Business Model
© Alzchem Group AG / August 2023 “VERBUND” — FULLY INTEGRATED BUSINESS MODEL AN Benefits of the “Verbund” system approach tay O Segment Specialty Chemicals BENEFITS OF “VERBUND” O Segment . oo. Basics & Inter- * Full control of product quality and specifications mediates * Lower costs * Higher finan
Slide 35: Our Products and Markets
© Alzchem Group AG / August 2022 OUR PRODUCTS AND MARKETS i, iN Successful with proven and new products in various industries (ay MAIN PRODUCTS DESCRIPTION END-MARKETS CREAMINO’ = Anutritional additive for poultry and pigs Feed additive © Creapure’ Creapure®, premium brand for creatine monohydrate a
Slide 36: Our Products and Markets
© Alzchem Group AG / August 2022 OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MS Pharmaceutical MAIN PRODUCTS DESCRIPTION END-MARKETS @ Calcium carbide-based mixtures for hot metal desulphurization Steel industry ny Guanidine Salts Fuel for airbags, key prod
Slide 37: Implementing Operating Targets
IMPLEMENTING OPERATING TARGETS Focus on the key growth drivers and sustainability IMPROVEMENT ~ GROWTH 4, SUSTAINABILITY * Raw material price increases at * Volume growth and full utilization of [4 * Vision 0 accidents and O waste least passed on to the market realized capex (Creapure®, : fi a EY '
Slide 38: Key Share Data
© Alzchem Group AG / OCtober 2023 KEY SHARE DATA Share Details as of October 24, 2023 SHARES OUTSTANDING LAST CLOSING PRICE MARKET CAPITALIZATION TICKER WKN ISIN LISTING DESIGNATED SPONSOR 10,176,335 EUR 19.55 EUR 199m ACT A2YNT3 DEOOOA2YNT30 Frankfurt Stock Exchange — Prime Standard Baader Bank AG